Clinical Data from Multiple Trials Showed Improvements in Both Motor and Non-Motor SymptomsJERUSALEM and BURLINGTON, Mass., April 04, 2024 (GLOBE...
Mean Plasma Tofacitinib Concentration Following administration of a single oral dose of 5 mg and 10 mg BT-600 All pharmacokinetic...
SYDNEY, Australia, April 04, 2024 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q), the Company developing a new...
Central Georgia Cancer Care Joins American Oncology Network to Elevate Local Cancer Care Delivery From left to right: Bradley T....
TPST-1120, a first-in-class, oral, selective PPAR⍺ antagonist, demonstrates clinical activity in PD-1 inhibitor refractory and immune compromised cancersBased on subsequent...
CAMBRIDGE, MA / ACCESSWIRE / April 3, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that interim data for a first-in-human,...
Boston, Massachusetts--(Newsfile Corp. - April 3, 2024) - Social Impact Partners is proud to announce the successful conclusion of the...
In a preclinical model of pulmonary fibrosis, a Surrozen antibody-based SWAP platform molecule decreased pulmonary inflammation and fibrosis and improved...
Meeting to discuss potential of IkT-001Pro as a disease modifying treatment for Pulmonary Arterial HypertensionBOSTON and ATLANTA, April 03, 2024...
WARREN, N.J., April 03, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc (‘Tevogen Bio’) (Nasdaq: TVGN), a clinical-stage biotech company,...
- Achievement of latest clinical candidate triggers additional $5 million milestone payment to CytomX and is the third milestone achieved...
PITTSBURGH, April 03, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: “LIPO”) (“Lipella,” “our,” “us” or the “Company”), a clinical-stage...
MISSISSAUGA, Ontario, April 03, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that FeraMAX®...
ENVASARC Trial is Fully Enrolled and Final Data are Expected in Third Quarter 2024 SAN DIEGO, April 03, 2024 (GLOBE...
BERLIN, GERMANY / ACCESSWIRE / April 3, 2024 / Berlin Cures, a biotechnology company in Phase II clinical trial for...
NAPLES, FL / ACCESSWIRE / April 2, 2024 / Stemtech Corporation (OTCQB:STEK), a leading company in the stem cell nutritional...
Company builds on its strengths to advance patient access, product innovation, culture and inclusion and diversityPRINCETON, NJ / ACCESSWIRE /...
SAN DIEGO, CA / ACCESSWIRE / April 2, 2024 / Rancho Biosciences, a data Science Services company known for its...
Topline results expected summer of 2024DURHAM, NC / ACCESSWIRE / April 2, 2024 / Vogenx, Inc., a clinical-stage developer of...
Dr. Massimo Radaelli's core focus will be on further expanding Jaguar's commercial footprint outside the U.S.Dr. Radaelli was instrumental in...